Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'caspase 10'
(id=5917503 ; fe=caspase 10 ; type=777 ; niveau=200 ; luminosité=25 ; somme entrante=1808 creation date=2017-05-30 touchdate=2025-07-24 23:04:11.000)
≈ 64 relations sortantes

  1. caspase 10 -- r_associated #0: 156 / 1 -> chimie
    n1=caspase 10 | n2=chimie | rel=r_associated | relid=0 | w=156
  2. caspase 10 -- r_associated #0: 84 / 0.538 -> caspase
    n1=caspase 10 | n2=caspase | rel=r_associated | relid=0 | w=84
  3. caspase 10 -- r_associated #0: 60 / 0.385 -> en:caspase 10 c
    n1=caspase 10 | n2=en:caspase 10 c | rel=r_associated | relid=0 | w=60
  4. caspase 10 -- r_associated #0: 60 / 0.385 -> en:drug effect
    n1=caspase 10 | n2=en:drug effect | rel=r_associated | relid=0 | w=60
  5. caspase 10 -- r_associated #0: 60 / 0.385 -> en:physiological aspects
    n1=caspase 10 | n2=en:physiological aspects | rel=r_associated | relid=0 | w=60
  6. caspase 10 -- r_associated #0: 59 / 0.378 -> en:aspects of adverse effects
    n1=caspase 10 | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=59
  7. caspase 10 -- r_associated #0: 59 / 0.378 -> en:caspase-6
    n1=caspase 10 | n2=en:caspase-6 | rel=r_associated | relid=0 | w=59
  8. caspase 10 -- r_associated #0: 59 / 0.378 -> en:cellular secretion
    n1=caspase 10 | n2=en:cellular secretion | rel=r_associated | relid=0 | w=59
  9. caspase 10 -- r_associated #0: 59 / 0.378 -> en:cysteine proteases
    n1=caspase 10 | n2=en:cysteine proteases | rel=r_associated | relid=0 | w=59
  10. caspase 10 -- r_associated #0: 58 / 0.372 -> en:aspects of radiation effects
    n1=caspase 10 | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=58
  11. caspase 10 -- r_associated #0: 58 / 0.372 -> en:caspase 12
    n1=caspase 10 | n2=en:caspase 12 | rel=r_associated | relid=0 | w=58
  12. caspase 10 -- r_associated #0: 58 / 0.372 -> en:caspase-5
    n1=caspase 10 | n2=en:caspase-5 | rel=r_associated | relid=0 | w=58
  13. caspase 10 -- r_associated #0: 58 / 0.372 -> en:chemical aspects
    n1=caspase 10 | n2=en:chemical aspects | rel=r_associated | relid=0 | w=58
  14. caspase 10 -- r_associated #0: 58 / 0.372 -> en:deficiency aspects
    n1=caspase 10 | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=58
  15. caspase 10 -- r_associated #0: 57 / 0.365 -> en:caspase 10 d
    n1=caspase 10 | n2=en:caspase 10 d | rel=r_associated | relid=0 | w=57
  16. caspase 10 -- r_associated #0: 57 / 0.365 -> en:in cerebrospinal fluid
    n1=caspase 10 | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=57
  17. caspase 10 -- r_associated #0: 57 / 0.365 -> en:standards characteristics
    n1=caspase 10 | n2=en:standards characteristics | rel=r_associated | relid=0 | w=57
  18. caspase 10 -- r_associated #0: 56 / 0.359 -> en:caspase-9
    n1=caspase 10 | n2=en:caspase-9 | rel=r_associated | relid=0 | w=56
  19. caspase 10 -- r_associated #0: 56 / 0.359 -> en:exposure as collected domain
    n1=caspase 10 | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=56
  20. caspase 10 -- r_associated #0: 56 / 0.359 -> en:poisoning aspects
    n1=caspase 10 | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=56
  21. caspase 10 -- r_associated #0: 56 / 0.359 -> en:taxonomic
    n1=caspase 10 | n2=en:taxonomic | rel=r_associated | relid=0 | w=56
  22. caspase 10 -- r_associated #0: 55 / 0.353 -> en:autoimmune lymphoproliferative syndrome
    n1=caspase 10 | n2=en:autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=55
  23. caspase 10 -- r_associated #0: 55 / 0.353 -> en:bioformation
    n1=caspase 10 | n2=en:bioformation | rel=r_associated | relid=0 | w=55
  24. caspase 10 -- r_associated #0: 55 / 0.353 -> en:casp10 wt allele
    n1=caspase 10 | n2=en:casp10 wt allele | rel=r_associated | relid=0 | w=55
  25. caspase 10 -- r_associated #0: 55 / 0.353 -> en:caspase-10b
    n1=caspase 10 | n2=en:caspase-10b | rel=r_associated | relid=0 | w=55
  26. caspase 10 -- r_associated #0: 55 / 0.353 -> en:caspase-7
    n1=caspase 10 | n2=en:caspase-7 | rel=r_associated | relid=0 | w=55
  27. caspase 10 -- r_associated #0: 55 / 0.353 -> en:historical aspects qualifier
    n1=caspase 10 | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=55
  28. caspase 10 -- r_associated #0: 55 / 0.353 -> en:therapeutic use - qualifier
    n1=caspase 10 | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=55
  29. caspase 10 -- r_associated #0: 55 / 0.353 -> en:ultrastructure
    n1=caspase 10 | n2=en:ultrastructure | rel=r_associated | relid=0 | w=55
  30. caspase 10 -- r_associated #0: 54 / 0.346 -> en:casp10 gene
    n1=caspase 10 | n2=en:casp10 gene | rel=r_associated | relid=0 | w=54
  31. caspase 10 -- r_associated #0: 54 / 0.346 -> en:caspase-2
    n1=caspase 10 | n2=en:caspase-2 | rel=r_associated | relid=0 | w=54
  32. caspase 10 -- r_associated #0: 54 / 0.346 -> en:caspase-8
    n1=caspase 10 | n2=en:caspase-8 | rel=r_associated | relid=0 | w=54
  33. caspase 10 -- r_associated #0: 54 / 0.346 -> en:mechanism of action qualifier
    n1=caspase 10 | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=54
  34. caspase 10 -- r_associated #0: 53 / 0.34 -> en:caspase-1
    n1=caspase 10 | n2=en:caspase-1 | rel=r_associated | relid=0 | w=53
  35. caspase 10 -- r_associated #0: 53 / 0.34 -> en:caspases, initiator
    n1=caspase 10 | n2=en:caspases, initiator | rel=r_associated | relid=0 | w=53
  36. caspase 10 -- r_associated #0: 53 / 0.34 -> en:genetic aspects
    n1=caspase 10 | n2=en:genetic aspects | rel=r_associated | relid=0 | w=53
  37. caspase 10 -- r_associated #0: 53 / 0.34 -> en:in blood
    n1=caspase 10 | n2=en:in blood | rel=r_associated | relid=0 | w=53
  38. caspase 10 -- r_associated #0: 53 / 0.34 -> en:pharmacokinetic aspects
    n1=caspase 10 | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=53
  39. caspase 10 -- r_associated #0: 52 / 0.333 -> en:chemical synthesis
    n1=caspase 10 | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=52
  40. caspase 10 -- r_associated #0: 52 / 0.333 -> en:fas-associated death domain protein
    n1=caspase 10 | n2=en:fas-associated death domain protein | rel=r_associated | relid=0 | w=52
  41. caspase 10 -- r_associated #0: 51 / 0.327 -> en:toxicity aspects
    n1=caspase 10 | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=51
  42. caspase 10 -- r_associated #0: 50 / 0.321 -> caspases
    n1=caspase 10 | n2=caspases | rel=r_associated | relid=0 | w=50
  43. caspase 10 -- r_associated #0: 49 / 0.314 -> en:cysteine protease activity
    n1=caspase 10 | n2=en:cysteine protease activity | rel=r_associated | relid=0 | w=49
  44. caspase 10 -- r_associated #0: 40 / 0.256 -> en:caspase-10, human
    n1=caspase 10 | n2=en:caspase-10, human | rel=r_associated | relid=0 | w=40
  45. caspase 10 -- r_associated #0: 35 / 0.224 -> en:analysis aspect
    n1=caspase 10 | n2=en:analysis aspect | rel=r_associated | relid=0 | w=35
  46. caspase 10 -- r_associated #0: 35 / 0.224 -> en:contraindications aspect
    n1=caspase 10 | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=35
  47. caspase 10 -- r_associated #0: 35 / 0.224 -> en:cysteine proteinase
    n1=caspase 10 | n2=en:cysteine proteinase | rel=r_associated | relid=0 | w=35
  48. caspase 10 -- r_associated #0: 34 / 0.218 -> protéase à cystéine
    n1=caspase 10 | n2=protéase à cystéine | rel=r_associated | relid=0 | w=34
  49. caspase 10 -- r_associated #0: 32 / 0.205 -> en:caspase-4
    n1=caspase 10 | n2=en:caspase-4 | rel=r_associated | relid=0 | w=32
  50. caspase 10 -- r_associated #0: 32 / 0.205 -> en:immunology aspects
    n1=caspase 10 | n2=en:immunology aspects | rel=r_associated | relid=0 | w=32
  51. caspase 10 -- r_associated #0: 31 / 0.199 -> en:caspase-3
    n1=caspase 10 | n2=en:caspase-3 | rel=r_associated | relid=0 | w=31
  52. caspase 10 -- r_associated #0: 30 / 0.192 -> en:protease, mch4
    n1=caspase 10 | n2=en:protease, mch4 | rel=r_associated | relid=0 | w=30
  53. caspase 10 -- r_associated #0: 29 / 0.186 -> en:in urine
    n1=caspase 10 | n2=en:in urine | rel=r_associated | relid=0 | w=29
  54. caspase 10 -- r_associated #0: 28 / 0.179 -> en:caspase-10
    n1=caspase 10 | n2=en:caspase-10 | rel=r_associated | relid=0 | w=28
  55. caspase 10 -- r_associated #0: 27 / 0.173 -> en:metabolic aspects
    n1=caspase 10 | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=27
  56. caspase 10 -- r_associated #0: 5 / 0.032 -> calpaïne
    n1=caspase 10 | n2=calpaïne | rel=r_associated | relid=0 | w=5
  57. caspase 10 -- r_associated #0: 5 / 0.032 -> caspase 12
    n1=caspase 10 | n2=caspase 12 | rel=r_associated | relid=0 | w=5
  58. caspase 10 -- r_associated #0: 5 / 0.032 -> caspase 2
    n1=caspase 10 | n2=caspase 2 | rel=r_associated | relid=0 | w=5
  59. caspase 10 -- r_associated #0: 5 / 0.032 -> effet d'un médicament
    n1=caspase 10 | n2=effet d'un médicament | rel=r_associated | relid=0 | w=5
  60. caspase 10 -- r_associated #0: 5 / 0.032 -> en:calpain
    n1=caspase 10 | n2=en:calpain | rel=r_associated | relid=0 | w=5
  61. caspase 10 -- r_associated #0: 5 / 0.032 -> en:casp3 gene product
    n1=caspase 10 | n2=en:casp3 gene product | rel=r_associated | relid=0 | w=5
  62. caspase 10 -- r_associated #0: 5 / 0.032 -> en:caspases, effector
    n1=caspase 10 | n2=en:caspases, effector | rel=r_associated | relid=0 | w=5
  63. caspase 10 -- r_associated #0: 5 / 0.032 -> en:human
    n1=caspase 10 | n2=en:human | rel=r_associated | relid=0 | w=5
  64. caspase 10 -- r_associated #0: 5 / 0.032 -> human
    n1=caspase 10 | n2=human | rel=r_associated | relid=0 | w=5
≈ 60 relations entrantes

  1. en:caspase-10 --- r_associated #0: 35 --> caspase 10
    n1=en:caspase-10 | n2=caspase 10 | rel=r_associated | relid=0 | w=35
  2. caspase --- r_associated #0: 28 --> caspase 10
    n1=caspase | n2=caspase 10 | rel=r_associated | relid=0 | w=28
  3. caspases --- r_associated #0: 20 --> caspase 10
    n1=caspases | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  4. en:analysis aspect --- r_associated #0: 20 --> caspase 10
    n1=en:analysis aspect | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  5. en:aspects of adverse effects --- r_associated #0: 20 --> caspase 10
    n1=en:aspects of adverse effects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  6. en:aspects of radiation effects --- r_associated #0: 20 --> caspase 10
    n1=en:aspects of radiation effects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  7. en:autoimmune lymphoproliferative syndrome --- r_associated #0: 20 --> caspase 10
    n1=en:autoimmune lymphoproliferative syndrome | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  8. en:bioformation --- r_associated #0: 20 --> caspase 10
    n1=en:bioformation | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  9. en:casp10 gene --- r_associated #0: 20 --> caspase 10
    n1=en:casp10 gene | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  10. en:casp10 wt allele --- r_associated #0: 20 --> caspase 10
    n1=en:casp10 wt allele | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  11. en:caspase 10 c --- r_associated #0: 20 --> caspase 10
    n1=en:caspase 10 c | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  12. en:caspase 10 d --- r_associated #0: 20 --> caspase 10
    n1=en:caspase 10 d | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  13. en:caspase 12 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase 12 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  14. en:caspase-1 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-1 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  15. en:caspase-10, human --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-10, human | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  16. en:caspase-10b --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-10b | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  17. en:caspase-2 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-2 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  18. en:caspase-3 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-3 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  19. en:caspase-4 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-4 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  20. en:caspase-5 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-5 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  21. en:caspase-6 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-6 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  22. en:caspase-7 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-7 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  23. en:caspase-8 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-8 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  24. en:caspase-9 --- r_associated #0: 20 --> caspase 10
    n1=en:caspase-9 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  25. en:caspases, initiator --- r_associated #0: 20 --> caspase 10
    n1=en:caspases, initiator | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  26. en:cellular secretion --- r_associated #0: 20 --> caspase 10
    n1=en:cellular secretion | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  27. en:chemical aspects --- r_associated #0: 20 --> caspase 10
    n1=en:chemical aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  28. en:chemical synthesis --- r_associated #0: 20 --> caspase 10
    n1=en:chemical synthesis | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  29. en:contraindications aspect --- r_associated #0: 20 --> caspase 10
    n1=en:contraindications aspect | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  30. en:cysteine protease activity --- r_associated #0: 20 --> caspase 10
    n1=en:cysteine protease activity | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  31. en:cysteine proteases --- r_associated #0: 20 --> caspase 10
    n1=en:cysteine proteases | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  32. en:cysteine proteinase --- r_associated #0: 20 --> caspase 10
    n1=en:cysteine proteinase | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  33. en:deficiency aspects --- r_associated #0: 20 --> caspase 10
    n1=en:deficiency aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  34. en:drug effect --- r_associated #0: 20 --> caspase 10
    n1=en:drug effect | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  35. en:exposure as collected domain --- r_associated #0: 20 --> caspase 10
    n1=en:exposure as collected domain | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  36. en:fas-associated death domain protein --- r_associated #0: 20 --> caspase 10
    n1=en:fas-associated death domain protein | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  37. en:genetic aspects --- r_associated #0: 20 --> caspase 10
    n1=en:genetic aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  38. en:historical aspects qualifier --- r_associated #0: 20 --> caspase 10
    n1=en:historical aspects qualifier | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  39. en:immunology aspects --- r_associated #0: 20 --> caspase 10
    n1=en:immunology aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  40. en:in blood --- r_associated #0: 20 --> caspase 10
    n1=en:in blood | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  41. en:in cerebrospinal fluid --- r_associated #0: 20 --> caspase 10
    n1=en:in cerebrospinal fluid | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  42. en:in urine --- r_associated #0: 20 --> caspase 10
    n1=en:in urine | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  43. en:mechanism of action qualifier --- r_associated #0: 20 --> caspase 10
    n1=en:mechanism of action qualifier | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  44. en:metabolic aspects --- r_associated #0: 20 --> caspase 10
    n1=en:metabolic aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  45. en:pharmacokinetic aspects --- r_associated #0: 20 --> caspase 10
    n1=en:pharmacokinetic aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  46. en:physiological aspects --- r_associated #0: 20 --> caspase 10
    n1=en:physiological aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  47. en:poisoning aspects --- r_associated #0: 20 --> caspase 10
    n1=en:poisoning aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  48. en:protease, mch4 --- r_associated #0: 20 --> caspase 10
    n1=en:protease, mch4 | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  49. en:standards characteristics --- r_associated #0: 20 --> caspase 10
    n1=en:standards characteristics | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  50. en:taxonomic --- r_associated #0: 20 --> caspase 10
    n1=en:taxonomic | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  51. en:therapeutic use - qualifier --- r_associated #0: 20 --> caspase 10
    n1=en:therapeutic use - qualifier | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  52. en:toxicity aspects --- r_associated #0: 20 --> caspase 10
    n1=en:toxicity aspects | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  53. en:ultrastructure --- r_associated #0: 20 --> caspase 10
    n1=en:ultrastructure | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  54. protéase à cystéine --- r_associated #0: 20 --> caspase 10
    n1=protéase à cystéine | n2=caspase 10 | rel=r_associated | relid=0 | w=20
  55. Caspase --- r_associated #0: 10 --> caspase 10
    n1=Caspase | n2=caspase 10 | rel=r_associated | relid=0 | w=10
  56. caspase 12 --- r_associated #0: 10 --> caspase 10
    n1=caspase 12 | n2=caspase 10 | rel=r_associated | relid=0 | w=10
  57. taxinomique --- r_associated #0: 10 --> caspase 10
    n1=taxinomique | n2=caspase 10 | rel=r_associated | relid=0 | w=10
  58. chimie --- r_associated #0: 7 --> caspase 10
    n1=chimie | n2=caspase 10 | rel=r_associated | relid=0 | w=7
  59. en:caspase --- r_associated #0: 5 --> caspase 10
    n1=en:caspase | n2=caspase 10 | rel=r_associated | relid=0 | w=5
  60. syndrome lymphoprolifératif avec autoimmunité --- r_associated #0: 5 --> caspase 10
    n1=syndrome lymphoprolifératif avec autoimmunité | n2=caspase 10 | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr